246 related articles for article (PubMed ID: 4084339)
1. N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165), a new antiarrhythmic agent: effects on cardiac conduction.
Hidaka T; Hamasaki S; Aisaka K; Ishihara T; Morita M; Toyama J; Yamada K
Arzneimittelforschung; 1985; 35(9):1381-6. PubMed ID: 4084339
[TBL] [Abstract][Full Text] [Related]
2. Effects of N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate on the ventriculo-atrial conductivity of accessory pathways.
Satoh S; Watanabe J; Keitoku M; Kinoshita H; Sekiguchi N; Endoh S; Ohtsuka K; Hangai K; Morita M; Takishima T
Arzneimittelforschung; 1989 Aug; 39(8):908-11. PubMed ID: 2818680
[TBL] [Abstract][Full Text] [Related]
3. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T
Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380
[TBL] [Abstract][Full Text] [Related]
4. N-(2,6-Dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165): a new potent and long-acting antiarrhythmic agent.
Aisaka K; Hidaka T; Inomata N; Hamasaki S; Ishihara T; Morita M
Arzneimittelforschung; 1985; 35(8):1239-45. PubMed ID: 4074441
[TBL] [Abstract][Full Text] [Related]
5. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 3rd communication: effect on cardiovascular system.
Aisaka K; Hidaka T; Hattori Y; Inomata N; Ishihara T; Satoh F
Arzneimittelforschung; 1988 Oct; 38(10):1417-25. PubMed ID: 3196382
[TBL] [Abstract][Full Text] [Related]
6. Effects of SUN-1165, N-(2,6-dimethylphenyl)-8-pyrrolizidine acetamide hydrochloride hemihydrate, a new class I antiarrhythmic drug, on ventricular arrhythmias, intraventricular conduction, and the refractory period in canine myocardial infarction.
Hashimoto H; Satoh N; Nakashima M
J Cardiovasc Pharmacol; 1992 Mar; 19(3):417-24. PubMed ID: 1378123
[TBL] [Abstract][Full Text] [Related]
7. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 2nd communication: effect on the peripheral nervous system and peripheral organs.
Hirotsu I; Kihara T; Hattori Y; Hatta M; Hirose N; Ishihara T; Satoh F
Arzneimittelforschung; 1988 Oct; 38(10):1410-7. PubMed ID: 3196381
[TBL] [Abstract][Full Text] [Related]
8. Antiarrhythmic, electrophysiologic and hemodynamic effects of ACC-9358.
Brown BS; Calzadilla SV; Diemer MJ; Hartman JC; Reynolds RD
J Pharmacol Exp Ther; 1987 Dec; 243(3):1225-34. PubMed ID: 3694532
[TBL] [Abstract][Full Text] [Related]
9. Effect of lidocaine and methyl lidocaine on cardiac conduction.
Man RY; Dresel PE
J Pharmacol Exp Ther; 1977 Apr; 201(1):184-91. PubMed ID: 850138
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiologic effects of asocainol, a new antiarrhythmic agent with predominant class I action.
Thale J; Gülker H; Hagemense B; Rose D; Haverkamp W; Frenking B
Arzneimittelforschung; 1987 Jan; 37(1):14-6. PubMed ID: 3566851
[TBL] [Abstract][Full Text] [Related]
11. Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362).
Bergey JL; Sulkowski T; Much DR; Wendt RL
Arzneimittelforschung; 1983; 33(9):1258-68. PubMed ID: 6685506
[TBL] [Abstract][Full Text] [Related]
12. Effect of encainide and its two major metabolites on cardiac conduction.
Dresel PE
J Pharmacol Exp Ther; 1984 Jan; 228(1):180-6. PubMed ID: 6420542
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological effects of penticainide in the anaesthetized dog.
Sassine A; Brugada J; Munoz A; Romero-Ayala L; Masse C
Drugs Exp Clin Res; 1987; 13(1):15-20. PubMed ID: 3595440
[TBL] [Abstract][Full Text] [Related]
14. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
15. Comparative direct electrophysiological effects of propofol on the conduction system and ionic channels of rabbit hearts.
Wu MH; Su MJ; Sun SS
Br J Pharmacol; 1997 Jun; 121(4):617-24. PubMed ID: 9208126
[TBL] [Abstract][Full Text] [Related]
16. Experimental study on the electrophysiological effects of the combination of the antiarrhythmic drugs aprindine and verapamil.
Okishige K; Ohtomo K; Satoh T; Hiejima K
Arch Int Pharmacodyn Ther; 1991; 314():44-56. PubMed ID: 1824189
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo electrocardiographic evaluation of the novel calcium antagonist monatepil on cardiac conduction system.
Nose I; Kataoka T; Honda Y; Yamada T; Ikeno A; Fukuya F; Minato H; Takeyama K; Hosoki K; Karasawa T
Arzneimittelforschung; 1993 Jul; 43(7):722-8. PubMed ID: 8369002
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiologic, haemodynamic and antiarrhythmic effects of the new class Ic agent 1-(2'-biphenyloxy)-2-tert.-butylamino-propanol-2-hydrochloride.
Chiladakis I; Hindricks G; Haverkamp W; Vogt J; Gülker H
Arzneimittelforschung; 1989 Sep; 39(9):1130-2. PubMed ID: 2590263
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiological effects of carocainide (770207) on the dog heart.
Huerta F; Santamaria R; Pourrias B
Arch Int Pharmacodyn Ther; 1984 Feb; 267(2):289-98. PubMed ID: 6712362
[TBL] [Abstract][Full Text] [Related]
20. Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499].
Lynch JJ; Wallace AA; Stupienski RF; Baskin EP; Beare CM; Appleby SD; Salata JJ; Jurkiewicz NK; Sanguinetti MC; Stein RB
J Pharmacol Exp Ther; 1994 May; 269(2):541-54. PubMed ID: 7802864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
